Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Q21

K-Number: K221959 · 2023-08-31

ApplicantNeurofield, Inc.
Decision Date2023-08-31
Product CodeGWQ
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Q21 is a medical device manufactured by Neurofield, Inc.. It received FDA 510(k) clearance on 2023-08-31 under approval number K221959. The device is classified under product code GWQ. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Q21?

Q21 is a medical device that received FDA 510(k) clearance on 2023-08-31. It is manufactured by Neurofield, Inc.. The 510(k) number is K221959.

When was Q21 approved by the FDA?

Q21 received FDA 510(k) clearance on 2023-08-31, under approval number K221959.

What company makes Q21?

Q21 is manufactured by Neurofield, Inc..

What is the FDA product code for Q21?

The FDA product code for Q21 is GWQ.

Other Devices by Neurofield, Inc.

K240420NeuroField Analysis Suite K252951Genesis Sleep

Related Devices (Code: GWQ)

K163163XLTEK EMU40EX EEG HeadboxNatus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) K162595Trex_HDNatus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) K150498Discovery 24Brainmaster Technologies, Inc. K170138NEURONAUTEBioserenity K171781eVox SystemEvoke Neuroscience, Inc. K171124Nihon Kohden Wireless Input Unit WEE-1200Nihon Kohden Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑